Enhertu, a targeted cancer therapy from partners AstraZeneca and Daiichi Sankyo, may now be used as a first-line treatment for advanced cases of breast cancer, making it the first new approved ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

Vonjo shows promise in improving blood counts for myelofibrosis patients, enhancing quality of life by reducing anemia-related symptoms. Antibody-drug conjugates are increasingly used in metastatic ...

The CBD creams we’ve found to be most effective for pain relief tend to contain other ingredients that create a cooling sensation. It’s hard to say which ingredient is offering the bulk of the pain ...